Adenoviral vectors of canine origin
US6294377A · kind A · utility
19Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 1995 |
| Grant date | Sep 25, 2001 |
| Priority date | — |
| Expiry date | Nov 17, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10343
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention resides in use of a recombinant adenovirus of animal origin containing a heterologous DNA sequence for the preparation of a pharmaceutical composition intended for the therapeutic and/or surgical treatment of the human body.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.